CNBX Pharmaceuticals Inc. (CNBX) stock
CNBXOTCPharmaceutical PreparationsFiscal year ends August 31
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap $197.79KP/E –Yield –
CNBX Pharmaceuticals total assets
Total assets on the balance sheet at the end of each period.
CNBX Pharmaceuticals's total assets was $12.80K at May 31, 2026. For fiscal 2025 it was $18.44K, down 41.3% from the year before. Over ten years it grew -4.3% a year on average. The highest annual figure on record is $15.18M in fiscal 2019.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $18.44K | -41.3% |
| FY2024 | Aug 31, 2024 | $31.38K | -93.7% |
| FY2023 | Aug 31, 2023 | $499.04K | -38.5% |
| FY2022 | Aug 31, 2022 | $811.17K | -73.7% |
| FY2021 | Aug 31, 2021 | $3.08M | +38.7% |
| FY2020 | Aug 31, 2020 | $2.22M | -85.4% |
| FY2019 | Aug 31, 2019 | $15.18M | +376.7% |
| FY2018 | Aug 31, 2018 | $3.18M | -12.4% |
| FY2017 | Aug 31, 2017 | $3.64M | +15238.8% |
| FY2016 | Aug 31, 2016 | $23.72K | -17.4% |
| FY2015 | Aug 31, 2015 | $28.70K | -74.9% |
| FY2014 | Aug 31, 2014 | $114.22K | +57.0% |
| FY2013 | Aug 31, 2013 | $72.76K | -23.4% |
| FY2010 | Aug 31, 2010 | $94.96K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | May 31, 2026 | $12.80K | -31.3% |
| Q2 FY2026CQ1 2026 | Feb 28, 2026 | $14.90K | -70.6% |
| Q1 FY2026CQ4 2025 | Nov 30, 2025 | $11.16K | -50.0% |
| Q4 FY2025CQ3 2025 | Aug 31, 2025 | $18.44K | -41.3% |
| Q3 FY2025CQ2 2025 | May 31, 2025 | $18.62K | -76.7% |
| Q2 FY2025CQ1 2025 | Feb 28, 2025 | $50.66K | -69.1% |
| Q1 FY2025CQ4 2024 | Nov 30, 2024 | $22.31K | -94.2% |
| Q4 FY2024CQ3 2024 | Aug 31, 2024 | $31.38K | -93.7% |
| Q3 FY2024CQ2 2024 | May 31, 2024 | $80.03K | -87.9% |
| Q2 FY2024CQ1 2024 | Feb 29, 2024 | $163.92K | -64.5% |
| Q1 FY2024CQ4 2023 | Nov 30, 2023 | $387.40K | -36.4% |
| Q4 FY2023CQ3 2023 | Aug 31, 2023 | $499.04K | -38.5% |
| Q3 FY2023CQ2 2023 | May 31, 2023 | $662.02K | -31.4% |
| Q2 FY2023CQ1 2023 | Feb 28, 2023 | $462.05K | -59.4% |
| Q1 FY2023CQ4 2022 | Nov 30, 2022 | $609.51K | -71.3% |
| Q4 FY2022CQ3 2022 | Aug 31, 2022 | $811.17K | -73.7% |
| Q3 FY2022CQ2 2022 | May 31, 2022 | $965.74K | -74.6% |
| Q2 FY2022CQ1 2022 | Feb 28, 2022 | $1.14M | -77.1% |
| Q1 FY2022CQ4 2021 | Nov 30, 2021 | $2.12M | +24.8% |
| Q4 FY2021CQ3 2021 | Aug 31, 2021 | $3.08M | +38.7% |
| Q3 FY2021CQ2 2021 | May 31, 2021 | $3.80M | -31.2% |
| Q2 FY2021CQ1 2021 | Feb 28, 2021 | $4.97M | +39.1% |
| Q1 FY2021CQ4 2020 | Nov 30, 2020 | $1.70M | -73.7% |
| Q4 FY2020CQ3 2020 | Aug 31, 2020 | $2.22M | -85.4% |
| Q3 FY2020CQ2 2020 | May 31, 2020 | $5.53M | -72.0% |
| Q2 FY2020CQ1 2020 | Feb 29, 2020 | $3.57M | -80.5% |
| Q1 FY2020CQ4 2019 | Nov 30, 2019 | $6.46M | -31.9% |
| Q4 FY2019CQ3 2019 | Aug 31, 2019 | $15.18M | +376.7% |
| Q3 FY2019CQ2 2019 | May 31, 2019 | $19.77M | +525.7% |
| Q2 FY2019CQ1 2019 | Feb 28, 2019 | $18.34M | +392.8% |
| Q1 FY2019CQ4 2018 | Nov 30, 2018 | $9.48M | +209.7% |
| Q4 FY2018CQ3 2018 | Aug 31, 2018 | $3.18M | -12.4% |
| Q3 FY2018CQ2 2018 | May 31, 2018 | $3.16M | -8.8% |
| Q2 FY2018CQ1 2018 | Feb 28, 2018 | $3.72M | +529.2% |
| Q1 FY2018CQ4 2017 | Nov 30, 2017 | $3.06M | +982.0% |
| Q4 FY2017CQ3 2017 | Aug 31, 2017 | $3.64M | +15238.8% |
| Q3 FY2017CQ2 2017 | May 31, 2017 | $3.46M | – |
| Q2 FY2017CQ1 2017 | Feb 28, 2017 | $591.64K | – |
| Q1 FY2017CQ4 2016 | Nov 30, 2016 | $282.96K | – |
| Q4 FY2016CQ3 2016 | Aug 31, 2016 | $23.72K | – |
See a number that looks wrong?